SCHEMBL249356

SCHEMBL249356

CCN1[CH]CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL249604 0.92
SCHEMBL6506979 0.90
SCHEMBL689547 0.79
SCHEMBL3392366 0.79
SCHEMBL5161248 0.74
SCHEMBL9167013 0.72 GNAI3 (0.38)
SCHEMBL4924070 0.72
SCHEMBL607241 0.72
SCHEMBL2074987 0.69
SCHEMBL9664573 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 420 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115109036-B Quinazoline compound, composition and application thereof 北京赛特明强医药科技有限公司 2024-06-11 CN claimed
US-20240101553-A1 KRAS G12C INHIBITORS MIRATI THERAPEUTICS INC (US) 2024-03-28 US claimed
CN-115894486-B Hydrogenated pyridoquinazoline compound, composition and application thereof 北京赛特明强医药科技有限公司 2024-02-09 CN claimed
EP-4293016-A1 QUINAZOLINE-BASED COMPOUND, COMPOSITION, AND APPLICATION OF QUINAZOLINE-BASED COMPOUND Beijing Scitech-MQ Pharmaceuticals Limited (CN) 2023-12-20 EP claimed
CN-116854649-A Gemini quaternary ammonium base type structure directing agent, preparation method thereof, AFX molecular sieve, preparation method thereof and application thereof 华东理工大学 2023-10-10 CN claimed
WO-2023186171-A1 CATIONIC LIPID, LIPOSOME, LIPID NANOPARTICLE, AND USE 科镁信(上海)生物医药科技有限公司 2023-10-05 WO claimed
CN-116554109-A Inhibitors of bruton's tyrosine kinase and methods of preparing the same 中山大学 2023-08-08 CN claimed
WO-2023051687-A1 QUINAZOLINE COMPOUND, COMPOSITION, AND APPLICATION THEREOF 北京赛特明强医药科技有限公司 2023-04-06 WO claimed
CN-115894486-A Hydrogenated pyridoquinazoline compound, composition and application thereof 北京赛特明强医药科技有限公司 2023-04-04 CN claimed
CN-115894455-A Quinazoline compound, composition and application thereof 北京赛特明强医药科技有限公司 2023-04-04 CN claimed
CN-1212694-A Pyrimido [5,4-D] pyrimidines, medicaments containing these compounds, their use and process for their production THOMAE GMBH DR K (DE) 1999-03-31 CN claimed
EP-0888351-A1 PYRIMIDO 5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION Dr. Karl Thomae GmbH (DE) 1999-01-07 EP claimed
US-5705497-A INOTROPIC, ANTIARRHYTHMIA AGENTS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1998-01-06 US claimed
WO-1997032880-A1 PYRIMIDO[5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION DR. KARL THOMAE GMBH (DE) 1997-09-12 WO claimed
US-5367062-A Disubstituted and deoxydisubstituted derivatives of α-d-lyxofuranosides having anti-inflammatory and anti-proliferative activity MEDICARB INC. (US) 1994-11-22 US claimed
US-RE33907-E Anti-spasmodic agents having a heterocyclic ring UNITED PHARMACEUTICALS, INC. (US) 1992-04-28 US claimed
CN-1051359-A Improved imidazo [4, the 5-b] quinolinyloxyalkanoic acid amides of water-soluble degree BRISTOL MYERS SQUIBB CO (US) 1991-05-15 CN claimed
EP-0213326-B1 2,5-DIMETHYL PYRROLE DERIVATIVES, THEIR PREPARATION AND THEIR USE CASSELLA Aktiengesellschaft (DE) 1991-03-06 EP claimed
US-4721783-A SMOOTH MUSCLES UNITED PHARMACEUTICALS, INC. (US) 1988-01-26 US claimed
EP-0000174-B1 DERIVATIVES OF AMINOBENZOIC ACIDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. Ludwig Merckle GmbH &amp; Co. chem.-pharm. Fabrik (DE) 1981-12-30 EP claimed